Timothy E. Tatum
Known title: VP Regulatory AffairsCIK: 0002078099
Associated companies
Transaction History
| IDA | ▼ Sell | Open Market | 1,479 | $211K | 3/3/2026 | View on chart |
| IDA | ▲ Buy | Grant | 2,019 | — | 2/20/2026 | View on chart |
| IDA | ▼ Sell | Tax Withholding | 911 | $127K | 2/20/2026 | View on chart |
| IDA | ▼ Sell | Tax Withholding | 311 | $40K | 1/2/2026 | View on chart |
| IDA | ▲ Buy | Option Exercise | 622 | $0 | 1/1/2026 | View on chart |
| IDA | ▼ Sell | Open Market | 2,006 | $231K | 3/12/2025 | View on chart |
| IDA | ▲ Buy | Grant | 1,070 | — | 2/21/2025 | View on chart |
| IDA | ▼ Sell | Tax Withholding | 505 | $58K | 2/21/2025 | View on chart |
| IDA | ▼ Sell | Tax Withholding | 270 | $29K | 1/2/2025 | View on chart |
| IDA | ▲ Buy | Option Exercise | 535 | $0 | 1/1/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays Lowers Idacorp Price Target to $149
Barclays maintained its overweight rating on Idacorp but reduced its price target to $149. This action occurred alongside reports of rising customer demand and the company's upcoming third-quarter earnings release. The stock currently trades near the upper end of its 52-week range, with an average analyst target of $153.89.
Barclays Lowers Idacorp Price Target to $149. Barclays maintained its overweight rating on Idacorp but reduced its price target to $149. This action occurred alongside reports of rising customer demand and the company's upcoming third-quarter earnings release. The stock currently trades near the upper end of its 52-week range, with an average analyst target of $153.89.